NO. 74 Clinics Ltd Accounts

NO. 74 CLINICS LTD - Company Information






	NO. 74 Clinics Ltd

	Company No. 13353680
	Unaudited Accounts
	30 April 2023

at	30 April 2023
Company No.		13353680	2023	2022
			£	£

Called up share capital not paid			83	83

Fixed assets			16,418	23,423

Current assets			65,248	75,262
Prepayments and accrued income			51,100	23,275
Creditors: Amounts falling due within one year			(124,521)	(72,761)
Net current assets			(8,173)	25,776
Total assets less current liabilities			8,328	49,282


Accruals and deferred income			(3,992)	(8,572)
			4,336	40,710


Capital and reserves			4,336	40,710

NOTES TO THE ACCOUNTS

Basis of preparation

These accounts have been prepared in accordance with the micro-entity provisions of the small companies regime.

2	Employees
		2023	2022
		Number	Number
	The average monthly number of employees (including directors) during the year was:	1	0

3	Contingencies, guarantees and commitments
		2023	2022
		£	£
	Total of contingencies, guarantees and commitments	175,874	123,750





	Future commitments represents net amounts payable for lease of equipment and rental of premises.

General information

NO. 74 Clinics Ltd is a private company limited by shares and incorporated in England and Wales.

Its registered number is:

13353680

Its registered office is:

Its trading address is:

32 Esher Road

23 Ansdell Street

East Molesey

London

KT8 0AD

W8 5BN

For the year ended 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.

The accounts were approved by the board of directors on 15 January 2024 and signed on its behalf by:

H.C. Wyre - Director